Alhenc-Gelas M, Gandrille S, Aubry M L, Aiach M
Laboratoire d'Hémostase, Hôpital Broussais, Paris, France.
Thromb Haemost. 2000 Jan;83(1):86-92.
We analyzed the protein C gene (PROC) with the denaturing gradient gel electrophoresis (DGGE) scanning strategy in a series of 129 patients with suspected protein C (PC) deficiency (93 with low plasma PC levels and 36 with borderline level). At least one sequence variation was found in 104 of the 129 patients. Thirty-nine sequence variations (found in 72 patients) were already reported detrimental mutations. Thirty-three were novel sequence variations, of which 19 (found in 25 patients) were probably detrimental. Five novel mutations (A1T, R9H, S11R, S12R and K193Q) were associated with qualitative plasma PC deficiency, suggesting or confirming the functional importance of amino acids at these positions. This strategy confirmed the diagnosis of inherited PC deficiency in 79/93 (84.9%) patients with low plasma PC levels and 14/36 (38.8%) patients with borderline values. In order to explain abnormal PC levels observed in patients who did not carry detrimental mutations, screening for the -1654C/T and -1641A/G PROC promoter polymorphisms known to influence plasma PC concentrations was performed. The frequency of the CG allele associated with lower PC concentrations was slightly but not significantly lower in 82 heterozygotes for detrimental PROC gene mutations than in 36 patients with no identified detrimental mutations.
我们采用变性梯度凝胶电泳(DGGE)扫描策略,对129例疑似蛋白C(PC)缺乏症患者(93例血浆PC水平低,36例处于临界水平)的蛋白C基因(PROC)进行了分析。在129例患者中,104例至少发现了一种序列变异。39种序列变异(在72例患者中发现)已被报道为有害突变。33种为新的序列变异,其中19种(在25例患者中发现)可能有害。5种新突变(A1T、R9H、S11R、S12R和K193Q)与血浆PC定性缺乏有关,提示或证实了这些位置氨基酸的功能重要性。该策略在93例血浆PC水平低的患者中确诊了79例(84.9%)遗传性PC缺乏症,在36例临界值患者中确诊了14例(38.8%)。为了解释未携带有害突变患者中观察到的异常PC水平,对已知会影响血浆PC浓度的-1654C/T和-1641A/G PROC启动子多态性进行了筛查。与较低PC浓度相关的CG等位基因频率,在82例有害PROC基因突变杂合子中略低于36例未发现有害突变的患者,但差异无统计学意义。